Report cover image

South & Central America Human Microbiome Market Report (2021-2031) by Scope, Segmentation, Dynamics, and Competitive Analysis

Publisher The Insight Partners
Published Sep 01, 2025
Length 128 Pages
SKU # TIP20577543

Description

The human microbiome market in South and Central America is projected to grow significantly, reaching approximately USD 147.22 million by 2031, up from USD 39.65 million in 2023, with an impressive compound annual growth rate (CAGR) of 17.8% during this period.

Executive Summary and Market Analysis

The market is divided into key regions: Brazil, Argentina, and the Rest of South and Central America. The growth of the human microbiome market in this region is supported by well-established healthcare systems, increased government support, and a rise in research and development activities. Additionally, the rising incidence of chronic diseases and the adoption of unhealthy lifestyles are expected to drive demand for microbiome-related products and services.

Market Segmentation

The South and Central America human microbiome market can be segmented based on type, application, and disease type:

Type: The market is categorized into products and software/services, with products dominating the market share in 2023. The product segment includes probiotics and prebiotics.
Application: The market is further divided into therapeutics, diagnostics, and research, with therapeutics holding the largest market share in 2023.
Disease Type: The market is segmented into obesity, diabetes, autoimmune disorders, cancer, gastrointestinal (GIT) issues, and others, with GIT issues leading the market in 2023.

Market Outlook

The human microbiome's potential to revolutionize healthcare has led to increased investments in research and development. The microbiome, consisting of trillions of microorganisms, plays a crucial role in maintaining health and preventing diseases. Biotech startups and pharmaceutical companies are heavily investing in microbiome-based therapies. For instance, Xome Life Sciences, a pioneering microbiome startup in India, is developing diagnostic and therapeutic tools aimed at improving health outcomes.

A notable example of microbiome innovation is the FDA-approved treatment by Seres Therapeutics for recurrent Clostridium difficile infections, showcasing the therapeutic potential of microbiome-based drugs. Companies like Vedanta Biosciences are also raising significant funds to develop immunotherapies derived from microbiomes for conditions such as autoimmune disorders and cancer. Investors like Seventure Partners and Flagship Pioneering are increasingly funding microbiome data analysis companies, highlighting the growing recognition of the microbiome's importance in health. This surge in investment is expected to drive advancements in precision medicine and therapeutic solutions, creating numerous opportunities in the market.

Country Insights

The South and Central America human microbiome market is primarily composed of Brazil, Argentina, and other countries in the region, with Brazil holding the largest market share in 2023. A recent study published in the Brazilian Journal of Infectious Diseases highlighted the analysis of the sputum microbiome in cystic fibrosis patients, revealing a high presence of Burkholderia cepacia complex (Bcc). This research could lead to improved diagnostic methods and treatments for chronic diseases, thereby increasing the demand for microbiome solutions in Brazil.

Pharmaceutical companies and biotech startups are actively investing in innovative microbiome therapeutics, leading to the development of new products. For example, in April 2023, Nintx, a startup based in São Paulo, Brazil, collaborated with federal institutions and private companies to create new drugs from plant-based natural products, receiving a USD 3 million investment from Pitanga venture capital in 2022 to accelerate their market entry. This trend of increasing research and investment is propelling the growth of the human microbiome market in Brazil.

Company Profiles

Key players in the human microbiome market include MaaT Pharma, Ferring Holdings SA, AOBiome Therapeutics Inc, Finch Therapeutics Group Inc, Seres Therapeutics Inc, Merck & Co Inc, Rebiotix, Inc., Yakult Honsha Co., Ltd., IFF Nutrition & Biosciences, and Synthetic Biologics, Inc. These companies are employing various strategies such as market expansion, product innovation, and mergers and acquisitions to enhance their offerings and increase their market presence.

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South & Central America human microbiome market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the South & Central America human microbiome market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth South & Central America market trends and outlook coupled with the factors driving the South & Central America human microbiome market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.

Table of Contents

128 Pages
1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macroeconomic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country-level data:
4. South & Central America Human Microbiome Market - Key Market Dynamics
4.1 Market Drivers
4.1.1 Significant Investments by Key Market Players
4.1.2 Government Initiatives
4.2 Market Restraints
4.2.1 Challenges During Production of Microbiome
4.3 Market Opportunities
4.3.1 Robust Investment in Research and Development
4.4 Future Trends
4.4.1 Emergence of Precision Medicine
4.5 Impact of Drivers and Restraints:
5. Human Microbiome Market - South & Central America Analysis
5.1 South & Central America Human Microbiome Market Revenue (US$ Million), 2021-2031
5.2 South & Central America Human Microbiome Market Forecast Analysis
6. South & Central America Human Microbiome Market Analysis - by Type
6.1 Product
6.1.1 Overview
6.1.2 Product: South & Central America Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million)
6.2 Software and Services
6.2.1 Overview
6.2.2 Software and Services: South & Central America Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million)
7. South & Central America Human Microbiome Market Analysis - by Application
7.1 Therapeutics
7.1.1 Overview
7.1.2 Therapeutics: South & Central America Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million)
7.2 Diagnostics
7.2.1 Overview
7.2.2 Diagnostics: South & Central America Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million)
7.3 Research
7.3.1 Overview
7.3.2 Research: South & Central America Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million)
8. South & Central America Human Microbiome Market Analysis - by Disease Type
8.1 Obesity
8.1.1 Overview
8.1.2 Obesity: South & Central America Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.2 Diabetes
8.2.1 Overview
8.2.2 Diabetes: South & Central America Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.3 Autoimmune Disorder
8.3.1 Overview
8.3.2 Autoimmune Disorder: South & Central America Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.4 Cancer
8.4.1 Overview
8.4.2 Cancer: South & Central America Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.5 GIT
8.5.1 Overview
8.5.2 GIT: South & Central America Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.6 Others
8.6.1 Overview
8.6.2 Others: South & Central America Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million)
9. South & Central America Human Microbiome Market - Country Analysis
9.1 South & Central America
9.1.1 South & Central America Human Microbiome Market - Revenue and Forecast Analysis - by Country
9.1.1.1 South & Central America Human Microbiome Market - Revenue and Forecast Analysis - by Country
9.1.1.2 Brazil: South & Central America Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million)
9.1.1.2.1 Brazil: South & Central America Human Microbiome Market Share - by Type
9.1.1.2.2 Brazil: South & Central America Human Microbiome Market Share - by Product
9.1.1.2.3 Brazil: South & Central America Human Microbiome Market Share - by Application
9.1.1.2.4 Brazil: South & Central America Human Microbiome Market Share - by Disease Type
9.1.1.3 Argentina: South & Central America Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million)
9.1.1.3.1 Argentina: South & Central America Human Microbiome Market Share - by Type
9.1.1.3.2 Argentina: South & Central America Human Microbiome Market Share - by Product
9.1.1.3.3 Argentina: South & Central America Human Microbiome Market Share - by Application
9.1.1.3.4 Argentina: South & Central America Human Microbiome Market Share - by Disease Type
9.1.1.4 Rest of South & Central America: South & Central America Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million)
9.1.1.4.1 Rest of South & Central America: South & Central America Human Microbiome Market Share - by Type
9.1.1.4.2 Rest of South & Central America: South & Central America Human Microbiome Market Share - by Product
9.1.1.4.3 Rest of South & Central America: South & Central America Human Microbiome Market Share - by Application
9.1.1.4.4 Rest of South & Central America: South & Central America Human Microbiome Market Share - by Disease Type
10. Competitive Landscape
10.1 Heat Map Analysis by Key Players
10.2 Company Positioning and Concentration
11. Industry Landscape
11.1 Overview
11.2 Growth Strategies in the Human Microbiome Market
11.3 Organic Growth Strategies
11.3.1 Overview
11.4 Inorganic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 MaaT Pharma
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Ferring Holdings SA
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 AOBiome Therapeutics Inc
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Finch Therapeutics Group Inc
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Financial Overview
12.4.4 SWOT Analysis
12.4.5 Key Developments
12.5 Seres Therapeutics Inc
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Merck & Co Inc
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Yakult Honsha Co., Ltd.
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Rebiotix, Inc.
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 IFF Nutrition & Biosciences
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Synthetic Biologics, Inc.
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About Us
13.2 List of Abbreviations
List of Tables
Table 1. South & Central America Human Microbiome Market Segmentation
Table 2. South & Central America Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million)
Table 3. South & Central America Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Type
Table 4. South & Central America Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Application
Table 5. South & Central America Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Disease Type
Table 6. South & Central America Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Country
Table 7. Brazil: South & Central America Human Microbiome Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
Table 8. Brazil: South & Central America Human Microbiome Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
Table 9. Brazil: South & Central America Human Microbiome Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 10. Brazil: South & Central America Human Microbiome Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Disease Type
Table 11. Argentina: South & Central America Human Microbiome Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
Table 12. Argentina: South & Central America Human Microbiome Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
Table 13. Argentina: South & Central America Human Microbiome Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 14. Argentina: South & Central America Human Microbiome Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Disease Type
Table 15. Rest of South & Central America: South & Central America Human Microbiome Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
Table 16. Rest of South & Central America: South & Central America Human Microbiome Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
Table 17. Rest of South & Central America: South & Central America Human Microbiome Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 18. Rest of South & Central America: South & Central America Human Microbiome Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Disease Type
Table 19. Recent Organic Growth Strategies in the Human Microbiome Market
Table 20. Recent Inorganic Growth Strategies in the Human Microbiome Market
Table 21. List of Abbreviations
 
List of Figures
Figure 1. South & Central America Human Microbiome Market Segmentation - Country
Figure 2. South & Central America Human Microbiome Market - Key Market Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. South & Central America Human Microbiome Market Revenue (US$ Million), 2021-2031
Figure 5. South & Central America Human Microbiome Market Share (%) - by Type (2023 and 2031)
Figure 6. Product: South & Central America Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 7. Software and Services: South & Central America Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 8. South & Central America Human Microbiome Market Share (%) - by Application (2023 and 2031)
Figure 9. Therapeutics: South & Central America Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 10. Diagnostics: South & Central America Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 11. Research: South & Central America Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 12. South & Central America Human Microbiome Market Share (%) - by Disease Type (2023 and 2031)
Figure 13. Obesity: South & Central America Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 14. Diabetes: South & Central America Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 15. Autoimmune Disorder: South & Central America Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 16. Cancer: South & Central America Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 17. GIT: South & Central America Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 18. Others: South & Central America Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 19. South & Central America Human Microbiome Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 20. Brazil: South & Central America Human Microbiome Market - Revenue and Forecast, 2021- 2031 (US$ Million)
Figure 21. Argentina: South & Central America Human Microbiome Market - Revenue and Forecast, 2021- 2031 (US$ Million)
Figure 22. Rest of South & Central America: South & Central America Human Microbiome Market - Revenue and Forecast, 2021- 2031 (US$ Million)
Figure 23. Heat Map Analysis by Key Players
Figure 24. Company Positioning and Concentration
Figure 25. Growth Strategies in the Human Microbiome Market
 

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us